GOOD SENSE MUCUS ER- guaifenesin tablet, extended release 
L. Perrigo Company

----------

Perrigo Mucus ER Drug Facts

Active ingredient (in each extended-release tablet)

Guaifenesin 1200 mg

Purpose

Expectorant

Uses

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Warnings

Do not use

•
for children under 12 years of age

Ask a doctor before use if you have

•
persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
•
cough accompanied by too much phlegm (mucus)

Stop use and ask a doctor if

•
cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

•
do not crush, chew, or break tablet
•
take with a full glass of water
•
this product can be administered without regard for the timing of meals
•
adults and children 12 years of age and over: 1 tablet every 12 hours. Do not exceed 2 tablets in 24 hours.
•
children under 12 years of age: do not use

Other information

•
store between 20°-25°C (68°-77°F)
•
do not use if printed foil under cap is broken or missing

Inactive ingredients

colloidal silicon dioxide, copovidone, FD&C blue #1 aluminum lake, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, sodium starch glycolate Type A, stearic acid

Questions or comments?

1-800-719-9260

Package/Label Principal Display Panel

12 Hour

Maximum Strength

Mucus - ER

Guaifenesin Extended-Release Tablets, 1200 mg

Expectorant

Relieves Chest Congestion

Thins and Loosens Mucus

Compare to active ingredient of Maximum Strength Mucinex®

100% SATISFACTION GUARANTEED

14 Extended-Release Tablets

325-c2-mucus er.jpg
GOOD SENSE MUCUS ER 
guaifenesin tablet, extended release
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0113-0325
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN1200 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
COPOVIDONE K25-31 (UNII: D9C330MD8B)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorBLUE (Light Blue) Scoreno score
ShapeOVAL (Biconvex) Size22mm
FlavorImprint Code Watson;1200
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0113-0325-661 in 1 CARTON09/19/201712/31/2021
114 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA09100909/19/201712/31/2021
Labeler - L. Perrigo Company (006013346)

Revised: 2/2024
Document Id: fc7b4f61-fd32-4938-8582-547c5ac0fa57
Set id: 8dcd36a1-4d3b-4435-9b6b-a2428b5c6744
Version: 3
Effective Time: 20240223
 
L. Perrigo Company